Anika Therapeutics Inc. (ANIK) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

to Matt Hall, Director of Corporate Development and Investor Relations. Please proceed. Thank you. Good morning and thank you for joining us for ANNICA's second quarter 2025 conference call and webcast. I'm Matt Hall, ANNICA's Director of Corporate Development and Investor Relations. Our earnings press release was issued earlier this morning and is available on our Investor Relations website located at .annica.com as are the supplementary PowerPoint slides that will be used for the discussion today. With me on the call are Dr. Cheryl Blanchard, President and Chief Executive Officer and Steve Griffin, Executive Vice President, Chief Financial Officer and Chief Operating Officer. We'll present our second quarter 2025 financial results and business highlights. Please take a moment and open the slide presentation and refer to slide number two. Before we begin, please understand that certain statements made during the call today constitute forward-looking statements as defined in the Securities Exchange Act of 1934. These statements are based on our current beliefs and expectations and are subject to certain risks and uncertainties. The company's actual results could differ materially from any anticipated future results, performance or achievements. We make no obligation to update these statements should future financial data or events occur that differ from the forward-looking statements presented today. Please also see our most recent SEC filings for more information about risk factors that could affect our performance. In addition, during the call we may refer to several adjusted or non-GAAP financial measures which may include adjusted EBITDA, adjusted net income from continuing operations and adjusted earnings per share from continuing operations which are used in ad...